TGFB1 and triple-negative breast carcinoma: ,75,76 Overactivation of the TGF-β signal pathway is said to increase the stemness of CSCs in triple-negative breast cancer; therefore, it is proposed that the prognosis of triple-negative breast cancer can be improved by combining traditional chemotherapy drugs with TGF-β inhibitors.77